Yiwen Zhao

Scientist, Immuno-Oncology at Codagenix Inc.
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
US

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Experience

  • Codagenix Inc.
    • United States
    • Biotechnology Research
    • 1 - 100 Employee
    • Scientist, Immuno-Oncology
      • Mar 2022 - Present

      Support preclinical development of oncolytic virus candidates for various cancers. Support preclinical development of oncolytic virus candidates for various cancers.

  • University of Rhode Island
    • Higher Education
    • 700 & Above Employee
    • Postdoctoral Fellow
      • Sep 2021 - Mar 2022

      Developed virus-like particles (VLPs) platform for recombinant subunit vaccine delivery, including Influenza, COVID and cancer vaccines. Developed virus-like particles (VLPs) platform for recombinant subunit vaccine delivery, including Influenza, COVID and cancer vaccines.

Education

  • University of Rhode Island
    Doctor of Philosophy - PhD, Biomedical and Pharmaceutical Sciences
    2016 - 2021
  • Temple University
    Master of Science - MS, Pharmaceutical Sciences
    2014 - 2016
  • China Pharmaceutical University
    Bachelor of Science - BS, Pharmaceutical Sciences
    2011 - 2015

Community

You need to have a working account to view this content. Click here to join now